Carcinoembryonic antigen (CEA) is a commonly used tumor marker, which has been extensively applied in the clinical diagnosis of various cancers, including liver, gastric, and pancreatic cancers [4,5,6,7]. This evidence concerns the gene CEACAM5 and cancer.